Lori Hu Resigns, Darcy Mootz Joins Elevation Oncology Board
Company Announcements

Lori Hu Resigns, Darcy Mootz Joins Elevation Oncology Board

Elevation Oncology (ELEV) has shared an announcement.

Lori Hu has resigned from her position on the Board of Directors of Elevation Oncology, Inc., effective April 5, 2024. Her departure is amicable, with no disagreements cited regarding the company’s operations or practices. The Board expresses gratitude for Hu’s contributions and welcomes Darcy Mootz, Ph.D., to the Audit Committee, where she will assume the role vacated by Hu.

For a thorough assessment of ELEV stock, go to TipRanks’ Stock Analysis page.

Related Articles
TheFlyElevation Oncology receives FTD from FDA for EO-3021
TipRanks Auto-Generated NewsdeskElevation Oncology Announces Preliminary Phase 1 Trial Results
TheFlyElevation Oncology’s EO-3021 shows ‘promising’ Phase 1 anti-tumor results
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App